Advisory Board. “We are very pleased to welcome Dr. Estabrooke to the URZ3 Advisory Board. Her unique combination of national security experience, advanced technology leadership, and direct uranium-sector board experience
URZ3 Energy Welcomes Dr. Ivy Estabrooke to the Advisory
Board
NEWS RELEASE
Vancouver, B.C. December 1, 2025 – URZ3 Energy Corp. (TSX.V: URZ) (OTCQB: URZEF) (“URZ3” or
the “ Company”) is pleased to announce Dr. Ivy V. Estabrooke has joined URZ3 as a member of the
Advisory Board.
“We are very pleased to welcome Dr. Estabrooke to the URZ3 Advisory Board. Her unique combination of
national security experience, advanced technology leadership, and direct uranium-sector board experience
will add tremendous depth to our strategic planning. Ivy’s background in deploying innovation at scale—
particularly in highly regulated environments—aligns perfectly with our vision as we advance URZ3’s U.S.-
focused uranium strategy,” stated Darcy Higgs, Director.
About Ivy V. Estabrooke, BA, MS, PhD
Ivy Estabrooke is an innovation executive with years of strategy, oversight, and leadership experience in
technology development and deployment in national security and health care environments. Dr. Estabrooke
serves on the board of Rare Earths Americas, an exploration stage rare earth company and previously
served on the board of Energy Fuels Inc. (NYSE: UUUU; TSX: EFR), a producer of uranium, vanadium,
and rare earth minerals. She has served on numerous nonprofit boards, including the Girl Scouts of Utah,
BioUtah, and the Utah District Export Council. Dr. Estabrooke started her career leading a technology
development portfolio for the US Department of the Navy where she fielded cutting-edge tools to the US
Marine Corps, intelligence community, and Special Forces community. She was the executive director of
the Utah Science Technology and Research Initiative, a technology-based economic development agency,
senior advisor to the Governor of Utah, and an executive at multiple biotech start-ups. She currently advises
government, public, and private entities in optimizing their approaches to innovation and technology
development for national security, economic, and social impact in her role as Strategic Account Executive
- Defense for RTI International, an independent scientific research institute. She holds the NACD.DC and
Department of Defense Senior Acquisition Professional certifications.
Dr. Estabrooke is a member of advisory boards at Arizona State University and The University of Texas at
Arlington. She is on the board of the Utah chapter of the National Association of Corporate Directors and
the Utah District Export Council.
Dr. Estabrooke has a doctorate in neuroscience from Georgetown University, a master’s degree in national
resource management from the National Defense University and a bachelor's degree in biological sciences
from Smith College. Her leadership has been recognized with the US Navy Meritorious Service Award, the
Fed 100, and a Pathfinder Award.
Corporate
The Company also announces that, pursuant to its stock option plan and subject to regulatory acceptance,
it has granted an aggregate total of 100,000 incentive stock options to Dr. Estabrooke, subject to certain
vesting provisions. These options will be exercisable at a price of $0.335 per common share and will expire
on November 28, 2030.
The stock option grant is subject to the receipt of all necessary regulatory filings and TSX-V approvals.
2
About URZ3 Energy Corp.
URZ3 Energy Corp. is a resource development company focused on the acquisition and exploration of
uranium properties in North America. The Company is dedicated to advancing its portfolio of projects to
meet the growing demand for uranium as a clean energy resource, leveraging its team’s extensive
experience in ISR uranium exploration, development, and production.
For more information about URZ3 Energy Corp., please visit www.urz3.com.
Contact:
Mark Kolebaba, President and CEO
Telephone: (604) 307-6450
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary statement regarding forward–looking information
Certain disclosures in this release constitute “forward-looking information” within the meaning of Canadian
securities legislation (such statements being referred to as “forward-looking statements”). Forward-looking
statements are statements that are not historical facts and are generally, but not always, identified by words
such as the following: expects, plans, anticipates, believes, intends, estimates, projects, assumes, potential
and similar expressions. Forward-looking statements involve risks, uncertainties and other factors that
could cause actual results, performance, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking statements. Factors that could cause actual results to differ
materially from these forward-looking statements include, but are not limited to, variations in the nature,
quality and quantity of any mineral deposits that may be located, the Company’s inability to obtain any
necessary permits, consents or authorizations required for its planned activities, and the Company’s
inability to raise the necessary capital or to be fully able to implement its business strategies. The reader is
referred to the Company’s public disclosure record which is available on SEDAR+ (sedarplus.ca). Although
the Company believes that the assumptions and factors used in preparing the forward-looking statements
are reasonable, undue reliance should not be placed on these statements, which only apply as of the date
of this news release, and no assurance can be given that such events will occur in the disclosed time frames
or at all. Except as required by securities laws and the policies of the TSX Venture Exchange, the Company
disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result
of new information, future events or otherwise.